1. Home
  2. TARA vs VEEA Comparison

TARA vs VEEA Comparison

Compare TARA & VEEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARA
  • VEEA
  • Stock Information
  • Founded
  • TARA N/A
  • VEEA 2014
  • Country
  • TARA United States
  • VEEA United States
  • Employees
  • TARA N/A
  • VEEA N/A
  • Industry
  • TARA Biotechnology: Biological Products (No Diagnostic Substances)
  • VEEA
  • Sector
  • TARA Health Care
  • VEEA
  • Exchange
  • TARA Nasdaq
  • VEEA NYSE
  • Market Cap
  • TARA 136.3M
  • VEEA 112.2M
  • IPO Year
  • TARA N/A
  • VEEA N/A
  • Fundamental
  • Price
  • TARA $4.26
  • VEEA $1.49
  • Analyst Decision
  • TARA Strong Buy
  • VEEA
  • Analyst Count
  • TARA 4
  • VEEA 0
  • Target Price
  • TARA $22.67
  • VEEA N/A
  • AVG Volume (30 Days)
  • TARA 225.7K
  • VEEA 22.2K
  • Earning Date
  • TARA 03-05-2025
  • VEEA 05-23-2025
  • Dividend Yield
  • TARA N/A
  • VEEA N/A
  • EPS Growth
  • TARA N/A
  • VEEA N/A
  • EPS
  • TARA N/A
  • VEEA N/A
  • Revenue
  • TARA N/A
  • VEEA $140,035.00
  • Revenue This Year
  • TARA N/A
  • VEEA N/A
  • Revenue Next Year
  • TARA N/A
  • VEEA N/A
  • P/E Ratio
  • TARA N/A
  • VEEA N/A
  • Revenue Growth
  • TARA N/A
  • VEEA N/A
  • 52 Week Low
  • TARA $1.60
  • VEEA $1.33
  • 52 Week High
  • TARA $10.48
  • VEEA $18.56
  • Technical
  • Relative Strength Index (RSI)
  • TARA 48.51
  • VEEA N/A
  • Support Level
  • TARA $4.41
  • VEEA N/A
  • Resistance Level
  • TARA $4.63
  • VEEA N/A
  • Average True Range (ATR)
  • TARA 0.27
  • VEEA 0.00
  • MACD
  • TARA 0.02
  • VEEA 0.00
  • Stochastic Oscillator
  • TARA 34.75
  • VEEA 0.00

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

About VEEA VEEA INC

Veea Inc is a company providing edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. It has first-in-class VeeaHub smart computing hubs integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.

Share on Social Networks: